Human bone marrow mesenchymal stem cell-derived hepatocytes express tissue inhibitor of metalloproteinases 4 and follistatin

Liver International

Volumn 35, Issue 10, 2015, Pages 2301-2310

  Xin, Jiaojiao ^a   Ding, Wenchao ^b   Hao, Shaorui ^a   Jiang, Longyan ^a   Zhou, Qian ^a   Wu, Tianzhou ^a   Shi, Dongyan ^a   Cao, Hongcui ^a   Li, Lanjuan ^a   Li, Jun ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

FST; Bone marrow mesenchymal stem cells; Hepatocyte; TIMP 4

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ACTIVIN A; ANGIOPOIETIN 1; BIOLOGICAL MARKER; FAS LIGAND; FOLLISTATIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; INTERCELLULAR ADHESION MOLECULE 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; INTERSTITIAL COLLAGENASE; LIPOTROPIN; NERVE CELL ADHESION MOLECULE; OSTEOPROTEGERIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR ALPHA POLYPEPTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TRANSFORMING GROWTH FACTOR BETA3; TRYPTOPHAN 2,3 DIOXYGENASE; TYROSINE AMINOTRANSFERASE; UNCLASSIFIED DRUG; VASCULOTROPIN A; XEDAR RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE-4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BONE MARROW MESENCHYMAL STEM CELL DERIVED HEPATOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FULMINANT HEPATIC FAILURE; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MINIPIG; NONHUMAN; NORMAL HUMAN; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL CULTURE; XENOTRANSPLANTATION; ANIMAL; BLOOD; CELL CULTURE; CELL TRANSDIFFERENTIATION; CHEMICALLY INDUCED; CHINA; DISEASE MODEL; GENETICS; LIVER FAILURE, ACUTE; MESENCHYMAL STROMA CELL; METABOLISM; PIG; XENOGRAFT;

ANIMALS; BIOMARKERS; CELL DIFFERENTIATION; CELL TRANSDIFFERENTIATION; CELLS, CULTURED; CHINA; DISEASE MODELS, ANIMAL; FEMALE; FOLLISTATIN; HEPATOCYTES; HUMANS; LIVER FAILURE, ACUTE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; SWINE; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANSPLANTATION, HETEROLOGOUS;

EID: 84942370492     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12797     Document Type: Article

References (31)

1. Viswanathan P, Gupta S. New directions for cell-based therapies in acute liver failure. J Hepatol 2012; 57: 913-5.
2. Fox IJ, Roy-Chowdhury J. Hepatocyte transplantation. J Hepatol 2004; 40: 878-86.
3. Kuroda Y, Kitada M, Wakao S, Dezawa M. Bone marrow mesenchymal cells: how do they contribute to tissue repair and are they really stem cells? Arch Immunol Ther Exp (Warsz) 2011; 59: 369-78.
4. Gilchrist ES, Plevris JN. Bone marrow-derived stem cells in liver repair: 10 years down the line. Liver Transpl 2010; 16: 118-29.
5. Liu TM, Martina M, Hutmacher DW, et al. Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells 2007; 25: 750-60.
6. Li J, Tao R, Wu W, et al. 3D PLGA scaffolds improve differentiation and function of bone marrow mesenchymal stem cell-derived hepatocytes. Stem Cells Dev 2010; 19: 1427-36.
7. Li J, Zhang L, Xin J, et al. Immediate intraportal transplantation of human bone marrow mesenchymal stem cells prevents death from fulminant hepatic failure in pigs. Hepatology 2012; 56: 1044-52.
8. Mitchell C, Fausto N. Bone marrow-derived hepatocytes: rare but promising. Am J Pathol 2002; 161: 349-50.
9. Li J, Tao R, Wu W, et al. Transcriptional profiling and hepatogenic potential of acute hepatic failure-derived bone marrow mesenchymal stem cells. Differentiation 2010; 80: 166-74.
10. Dalakas E, Newsome PN, Boyle S, et al. Bone marrow stem cells contribute to alcohol liver fibrosis in humans. Stem Cells Dev 2010; 19: 1417-25.
11. Morigi M, Introna M, Imberti B, et al. Human bone marrow mesenchymal stem cells accelerate recovery of acute rena l injury and prolong survival in mice. Stem Cells 2008; 26: 2075-82.
12. Peng L, Xie DY, Lin BL, et al. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology 2011; 54: 820-8.
13. Lim X, Tan SH, Koh WL, et al. Interfollicular epidermal stem cells self-renew via autocrine Wnt signaling. Science 2013; 342: 1226-30.
14. Da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44-57.
15. Da Huang W, Sherman BT, Tan Q, et al. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res 2007; 35: W169-75.
16. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-7.
17. Behbahan IS, Keating A, Gale RP. Concise review: bone marrow autotransplants for liver disease? Stem Cells 2013; 31: 2313-29.
18. Meier RP, Muller YD, Morel P, Gonelle-Gispert C, Buhler LH. Transplantation of mesenchymal stem cells for the treatment of liver diseases, is there enough evidence? Stem Cell Res 2013; 11: 1348-64.
19. Hung SC, Chen NJ, Hsieh SL, et al. Isolation and characterization of size-sieved stem cells from human bone marrow. Stem Cells 2002; 20: 249-58.
20. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-7.
21. Aurich H, Sgodda M, Kaltwasser P, et al. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut 2009; 58: 570-81.
22. Lee KD, Kuo TK, Whang-Peng J, et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 2004; 40: 1275-84.
23. Campard D, Lysy PA, Najimi M, Sokal EM. Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology 2008; 134: 833-48.
24. Hengstler JG, Brulport M, Schormann W, et al. Generation of human hepatocytes by stem cell technology: definition of the hepatocyte. Expert Opin Drug Metab Toxicol 2005; 1: 61-74.
25. Van Poll D, Parekkadan B, Cho CH, et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 2008; 47: 1634-43.
26. Lee SY, Kim JM, Cho SY, et al. TIMP-1 modulates chemotaxis of human neural stem cells through CD63 and integrin signalling. Biochem J 2014; 459: 565-76.
27. Wilk CM, Schildberg FA, Lauterbach MA, et al. The tissue inhibitor of metalloproteinases-1 improves migration and adhesion of hematopoietic stem and progenitor cells. Exp Hematol 2013; 41: 823-31 e822.
28. Egea V, Zahler S, Rieth N, et al. Tissue inhibitor of metalloproteinase-1 (TIMP-1) regulates mesenchymal stem cells through let-7f microRNA and Wnt/beta-catenin signaling. Proc Natl Acad Sci U S A 2012; 109: E309-16.
29. Sidis Y, Mukherjee A, Keutmann H, et al. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins. Endocrinology 2006; 147: 3586-97.
30. Phillips DJ, De Kretser DM. Follistatin: a multifunctional regulatory protein. Front Neuroendocrinol 1998; 19: 287-322.
31. Li CW, Ge W. Regulation of the activin-inhibin-follistatin system by bone morphogenetic proteins in the zebrafish ovary. Biol Reprod 2013; 89: 55.